Teva Pharmaceutical Industries Limited is believed to be in preliminary discussions to buy Handok Pharmaceuticals Co., Ltd., according to reports in JoongAng Dail. Young-Jin Kim, Chief Executive Officer and Chairman of Handok, holds 46.8% of Hando and IMM Private Equity owns 30% of Handok.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.34 USD | +2.91% | +4.27% | +66.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.09% | 19.64B | |
+48.53% | 780B | |
+40.67% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+16.75% | 244B | |
-1.19% | 217B | |
+10.85% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Reportedly In Talks To Acquire Handok Pharmaceuticals